ORKA Q2 2020 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$26,000

Operating Income

-$1M

Net Income

-$1M

EPS (Diluted)

$-8.71

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$1M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$12M

Total Liabilities

$1M

Stockholders' Equity

$10M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$26,000	-$22,000	-18.2%
Operating Income	-$1M	-$2M	+13.1%
Net Income	-$1M	-$1M	+9.3%